Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi BEL 20 UCITS ETF Dist

BEL · FR0000021842 · class Dist · EUR · domicile France
Equity · BelgioSFDR art. 6
Index tracked: Brussels Stock Exchange BEL20 Private Return Index Closing
TER
0.50%+ trans. 0.21%
Fund size
76 m EUR
Tracking difference
−0.60%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Mixed (acc. and/or dist.)
Launch 31 Jul 2002 · costs from the KID as of 2 Sept 2026 · 21 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Sub-fund is a passively managed index-based UCITS. The Sub-fund's objective is to replicate, both upwards and downwards, the performance of the BEL 20 Net Return Index (net dividends reinvested) (the "Benchmark"), denominated in euro (EUR) and representative of the largest companies listed on Euronext Brussels, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund prospectus. The Euronext website (www.euronext.com)…

Performance since series start (in euro) — base 100

1 Oct 20128 Sept 2026 · dividends reinvested where declared by the issuer
201320152017201920212023202531897315
High 318 (27 Aug 2026) · low 97 (14 Nov 2012) · last 315. Past performance is not indicative of future results.

Returns in euro

1 year+23.2%
3 years+66.1%
5 years+46.3%
10 years+90.1%
Since series start+215.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.52%13.70%14.69%
Max drawdown−13.49%−14.19%−25.38%
Sharpe1.310.950.35
Sortino2.021.360.50
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · BEL · FR00000218421
RebalixBEL · FR0000021842 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+21.20%+21.68%−0.48%
2024+16.51%+17.42%−0.91%
2023+2.10%+2.53%−0.42%
2022−12.88%−12.26%−0.62%
2021+20.74%+21.33%−0.60%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 21 securities · top-10 weight = 78.1%
Top holdingsWeight
ARGENX SE15.6%
KBC GROUP NV12.7%
ANHEUSER-BUSCH INBEV SA/NV BRUXELLES11.7%
UCB SA9.1%
AGEAS8.0%
AEDIFICA4.5%
ELIA GROUP SA/NV4.4%
ACKERMANS & VAN HAAREN4.2%
SYENSQO SA4.1%
GROUPE BRUXELLES LAMBERT NV3.8%
Countries (% of fund)
Belgium98.5%Netherlands1.5%
Sectors (% of fund)
Financials27.1%Health Care24.7%Consumer Staples15.5%Materials10.4%Real Estate8.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Euronext Brussels
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0000021842/ENG/DEU
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0000021842/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0000021842/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0000021842
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · BEL · FR00000218422